Brian D Hoit

Author PubWeight™ 83.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bimodal cardiac dysfunction in an animal model of iron overload. J Lab Clin Med 2002 2.23
2 Type 1 phosphatase, a negative regulator of cardiac function. Mol Cell Biol 2002 1.97
3 Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol Lung Cell Mol Physiol 2002 1.76
4 The essential role of Cited2, a negative regulator for HIF-1alpha, in heart development and neurulation. Proc Natl Acad Sci U S A 2002 1.64
5 Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 2004 1.64
6 The relation between quantitative right ventricular ejection fraction and indices of tricuspid annular motion and myocardial performance. J Am Soc Echocardiogr 2004 1.61
7 Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure. J Cardiovasc Electrophysiol 2006 1.60
8 Low carbohydrate/high-fat diet attenuates cardiac hypertrophy, remodeling, and altered gene expression in hypertension. Hypertension 2006 1.56
9 Differential effects of saturated and unsaturated fatty acid diets on cardiomyocyte apoptosis, adipose distribution, and serum leptin. Am J Physiol Heart Circ Physiol 2006 1.52
10 Validation of echocardiographic methods for assessing left ventricular dysfunction in rats with myocardial infarction. Am J Physiol Heart Circ Physiol 2004 1.52
11 Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovasc Res 2007 1.50
12 Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse. Cardiovasc Res 2013 1.45
13 Sex influences endothelial function in sleep-disordered breathing. Sleep 2004 1.44
14 Intrafamilial variability of noncompaction of the ventricular myocardium. Am Heart J 2006 1.41
15 Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 2002 1.38
16 Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc Res 2002 1.33
17 Rescue of cardiomyocyte dysfunction by phospholamban ablation does not prevent ventricular failure in genetic hypertrophy. J Clin Invest 2003 1.33
18 Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 2003 1.30
19 High-fat diet prevents cardiac hypertrophy and improves contractile function in the hypertensive dahl salt-sensitive rat. Clin Exp Pharmacol Physiol 2005 1.24
20 Pleiotropy, homeostasis, and functional networks based on assays of cardiovascular traits in genetically randomized populations. Genome Res 2003 1.22
21 Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure. Cardiovasc Res 2002 1.21
22 High fructose diet increases mortality in hypertensive rats compared to a complex carbohydrate or high fat diet. Am J Hypertens 2007 1.14
23 Effects of a high saturated fat diet on cardiac hypertrophy and dysfunction in response to pressure overload. J Card Fail 2008 1.13
24 High-fat diet postinfarction enhances mitochondrial function and does not exacerbate left ventricular dysfunction. Am J Physiol Heart Circ Physiol 2006 1.13
25 Stem cell therapy with overexpressed VEGF and PDGF genes improves cardiac function in a rat infarct model. PLoS One 2009 1.11
26 Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond. Transl Res 2011 1.11
27 Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol 2012 1.09
28 Prolonged exposure to high dietary lipids is not associated with lipotoxicity in heart failure. J Mol Cell Cardiol 2009 1.09
29 Effects of chronic activation of peroxisome proliferator-activated receptor-alpha or high-fat feeding in a rat infarct model of heart failure. Am J Physiol Heart Circ Physiol 2005 1.08
30 Strain-dependent beta-adrenergic receptor function influences myocardial responses to isoproterenol stimulation in mice. Am J Physiol Heart Circ Physiol 2005 1.08
31 Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure. Cardiovasc Res 2008 1.08
32 Targeted myocardial transgenic expression of HIV Tat causes cardiomyopathy and mitochondrial damage. Am J Physiol Heart Circ Physiol 2002 1.07
33 Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction. J Card Fail 2008 1.06
34 Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One 2009 1.04
35 Attenuation of oxidative stress and remodeling by cardiac inhibitor of metalloproteinase protein transfer. Circulation 2004 1.04
36 Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload. Am J Physiol Heart Circ Physiol 2007 1.03
37 Vascular reactivity in heart failure: role of myosin light chain phosphatase. Circ Res 2004 1.02
38 The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure. Am J Physiol Heart Circ Physiol 2010 1.01
39 Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis. Cardiovasc Res 2002 1.01
40 High-sugar diets increase cardiac dysfunction and mortality in hypertension compared to low-carbohydrate or high-starch diets. J Hypertens 2008 0.99
41 Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 2005 0.99
42 Carnitine palmitoyl transferase-I inhibition is not associated with cardiac hypertrophy in rats fed a high-fat diet. Clin Exp Pharmacol Physiol 2007 0.98
43 Dissociation between gene and protein expression of metabolic enzymes in a rodent model of heart failure. Eur J Heart Fail 2006 0.97
44 Differential regulation of p38 mitogen-activated protein kinase mediates gender-dependent catecholamine-induced hypertrophy. Cardiovasc Res 2003 0.92
45 Cardiac myosin binding protein C insufficiency leads to early onset of mechanical dysfunction. Circ Cardiovasc Imaging 2011 0.92
46 Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats. Am J Physiol Heart Circ Physiol 2007 0.91
47 Captopril prevents myosin light chain phosphatase isoform switching to preserve normal cGMP-mediated vasodilatation. J Mol Cell Cardiol 2006 0.90
48 Evaluation of left ventricular diastolic function from spectral and color M-mode Doppler in genetically altered mice. J Am Soc Echocardiogr 2002 0.89
49 Reduced force production during low blood flow to the heart correlates with altered troponin I phosphorylation. J Muscle Res Cell Motil 2009 0.88
50 Metalloproteinase in myocardial adaptation and maladaptation. J Cardiovasc Pharmacol Ther 2002 0.87
51 An unnatural history of left ventricular pseudoaneurysm? J Am Soc Echocardiogr 2010 0.87
52 Assessment of left ventricular mass in mice: comparison between two-dimensional and m-mode echocardiography. Echocardiography 2002 0.86
53 Comparison of velocity vector imaging echocardiography with magnetic resonance imaging in mouse models of cardiomyopathy. Circ Cardiovasc Imaging 2012 0.85
54 Assessing atrial mechanical remodeling and its consequences. Circulation 2005 0.84
55 Extensive nonbacterial thrombotic endocarditis isolated to the tricuspid valve in primary antiphospholipid syndrome. J Am Soc Echocardiogr 2009 0.84
56 Right ventricular systolic pressure assessed by echocardiography: a predictive factor of mortality in patients with scleroderma. Clin Cardiol 2011 0.84
57 The double jeopardy of blunt chest trauma: a case report and review. Echocardiography 2006 0.83
58 Compensated hypertrophy of cardiac ventricles in aged transgenic FVB/N mice overexpressing calsequestrin. Mol Cell Biochem 2003 0.81
59 Cocaine increases mortality and cardiac mass in a murine transgenic model of acquired immune deficiency syndrome. Lab Invest 2003 0.81
60 Reply: Feature tracking cardiac magnetic resonance imaging in the assessment of left atrial function. J Am Coll Cardiol 2014 0.81
61 Assessment of echocardiographic left atrial size: accuracy of M-mode and two-dimensional methods and prediction of diastolic dysfunction. Echocardiography 2012 0.81
62 Images in cardiovascular medicine. Case of anomalous right superior vena cava. Circulation 2006 0.80
63 Treatment of pericardial disease. Cardiovasc Ther 2010 0.79
64 Assessment of echocardiographic left atrial size: how accurate do we need to be? JACC Cardiovasc Imaging 2012 0.79
65 Prevalence of unsuspected and significant mitral and aortic regurgitation. J Am Soc Echocardiogr 2007 0.78
66 Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure. Fundam Clin Pharmacol 2006 0.78
67 Mouse strain-specific differences in cardiac metabolic enzyme activities observed in a model of isoproterenol-induced cardiac hypertrophy. Clin Exp Pharmacol Physiol 2007 0.78
68 Detection of myocardial dysfunction during cancer chemotherapy with tissue Doppler imaging: a canary in the coal mine? J Am Soc Echocardiogr 2009 0.77
69 Matrix metalloproteinases and atrial structural remodeling. J Am Coll Cardiol 2003 0.77
70 Routine transesophageal echocardiography for the evaluation of cerebral emboli in elderly patients. Echocardiography 2005 0.77
71 Excitation-contraction coupling in the MLP knockout mouse. J Mol Cell Cardiol 2006 0.76
72 Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy. Ther Adv Chronic Dis 2011 0.76
73 Evaluating the results of transcatheter versus surgical aortic valve replacement: the value of a core echocardiographic laboratory. J Am Coll Cardiol 2013 0.75
74 It's time to index the right ventricle, but to what and how? J Am Soc Echocardiogr 2012 0.75
75 Atrial functional mitral regurgitation: the left atrium gets its due respect. J Am Coll Cardiol 2011 0.75
76 The role of E2F1 in the development of hypertrophic cardiomyopathy. Int J Clin Exp Pathol 2011 0.75
77 Understanding the molecular regulation of T-wave alternans. Transl Res 2008 0.75
78 Hunting to prevent aortic stenosis. Circulation 2010 0.75
79 Echo and stem cell therapy: more than just an ejection fraction. J Am Soc Echocardiogr 2011 0.75
80 Left atrial coagulation activity in patient with mitral stenosis in sinus rhythm. J Med Assoc Thai 2013 0.75
81 Role of echocardiography in congestive heart failure. J Med Assoc Thai 2003 0.75
82 Real time embolization of a mitral valve vegetation. Echocardiography 2007 0.75
83 Relaxation... it's not getting any easier. J Mol Cell Cardiol 2002 0.75
84 A billiard ball in the left atrium. Echocardiography 2012 0.75
85 Papillary fibroelastoma of the pulmonic valve: evaluation by echocardiography and magnetic resonance imaging. Echocardiography 2008 0.75
86 The myocardial performance index in patients with aortic stenosis. Echocardiography 2002 0.75
87 Fetal diagnosis of superior vena cava aneurysm. Echocardiography 2012 0.75
88 Isoproterenol-induced myocardial injury: a systematic comparison of subcutaneous versus intraperitoneal delivery in a rat model. Echocardiography 2010 0.75
89 Cardiac papillary fibroelastoma mimicking left atrial appendage thrombus. J Am Soc Echocardiogr 2008 0.75